Skyhawktx’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Skyhawk Therapeutics is focused on the discovery and development of small molecule therapeutics that correct RNA expression. Read more

Bill Haney's photo - Co-Founder of Skyhawktx

Co-Founder

Bill Haney

CEO Approval Rating

70/100

Founded:

2015

Status:

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Skyhawktx's revenue?

Acquisitions

No recent acquisitions found related to Skyhawktx

Skyhawktx Funding History

$48M

Since Skyhawktx was founded in 2015, it has participated in 2 rounds of funding. In total Skyhawktx has raised $48.0M. Skyhawktx's last funding round was on Jun 2018 for a total of $40.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jun 2018
$40M

GreatPoint Ventures

Seed
Jan 2018
$8M
-

Total Funding: $48M

Since Skyhawktx was founded in 2015, it has participated in 2 rounds of funding. In total Skyhawktx has raised $48.0M. Skyhawktx's last funding round was on Jun 2018 for a total of $40.0M

Investments

No recent investments found related to Skyhawktx

Skyhawktx News

November 13, 2019BioPortfolio

Skyhawk and Celgene expand alliance to identify new drug targets

Skyhawk Therapeutics has formed a second alliance with an affiliate of Celgene to identify drug targe... See more »
September 4, 2019FinanzNachrichten

RNA Expert Dr. Phillip Sharp Joins as Advisor to Skyhawk Therapeutics

Dr. Sharp, winner of the Nobel Prize for his work discovering RNA splicing, joins as special advisor ... See more »
July 17, 2019The Pharma Letter

Skyhawk could earn up to $2 billion from big pharma deal

Privately-held US biotech Skyhawk Therapeutics has announced a multi-target exclusive option and lice... See more »
July 16, 2019Xconomy

Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery

Skyhawk Therapeutics has added Genentech to the growing list of companies it's working with to find n... See more »
July 8, 2019BioPortfolio

Skyhawk Therapeutics gibt Ausweitung des Kooperationsabkommens mit Biogen bekannt Biogen

Skyhawk wird Kooperation mit Biogen ausweiten um neue niedermolekulare RNASpleimodifikatoren fr Krank... See more »
July 8, 2019The Business Journals

Skyhawk Therapeutics adds Merck to nest of drug partners

Waltham biotech Skyhawk Therapeutics has plucked up a partnership deal with another major drugmaker, ... See more »

Skyhawktx Press Releases

Headquarters

35 Gatehouse Dr

Waltham, Massachusetts02451

617-858-0041

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Skyhawk Therapeutics is focused on the discovery and development of small molecule therapeutics that correct RNA expression. Skyhawktx was founded in 2015. Skyhawktx's headquarters is located in Waltham, Massachusetts, USA 02451. It has raised 48.0M i...

CEO

Skyhawktx's Co-Founder, Bill Haney, currently has an approval rating of 70%. Skyhawktx's primary competitors are

Website

skyhawktx.com

Frequently Asked Questions about Skyhawktx

  1. When was Skyhawktx founded?

    Skyhawktx was founded in 2015
  2. Who is Skyhawktx's CEO?

    Skyhawktx's CEO is Bill Haney
  3. How much revenue does Skyhawktx generate?

    Skyhawktx generates $ < 1M in revenue
  1. How much funding does Skyhawktx have?

    Skyhawktx has historically raised $48M in funding
  2. Where is Skyhawktx's headquarters?

    Skyhawktx's headquarters is in Waltham Massachusetts, USA
  3. How many employees does Skyhawktx have?

    Skyhawktx has 0 employees